View Full Company Profile

Cambridge Acquisition Corp.

CIK: 2100125 Filed: March 27, 2026 10-K

Key Highlights

  • Raised $200 million in capital to acquire a private company.
  • Targeting high-growth opportunities in the tech and healthcare sectors.
  • Provides a capital safety net with a $10.00 per share redemption value if no deal is reached.

Financial Analysis

Cambridge Acquisition Corp. Annual Report: A Simple Breakdown

This guide explains how Cambridge Acquisition Corp. performed this year. My goal is to cut through the corporate jargon so you can decide if this company fits your portfolio.

1. What does this company do?

Cambridge Acquisition Corp. is a "blank check" company. It does not sell products or services. Instead, it raised $200 million from investors to find and buy a private company. Once they find a partner, that private business takes over Cambridge’s spot on the Nasdaq under the ticker "CAMB."

2. Financial performance

Because this is a shell company, it has no sales revenue. Its 2025 activity focused on the legal and administrative work needed to go public. The company officially listed on the Nasdaq on February 6, 2026, selling 20 million units at $10.00 each. By year-end, the company reported a $450,000 loss, which covers the necessary legal, audit, and filing fees required to maintain the company.

3. Financial health

The company’s "wallet" is a pool of cash waiting for a future deal. They raised money by selling 20 million public shares and issuing 5 million "Founder" shares to the management team. To cover daily operating costs, management loaned the company $300,000. This interest-free loan is repayable only after a merger closes. Additionally, the company owes $7 million in banking fees, which are only payable if they successfully complete a deal.

4. Major risks

Investing in a SPAC comes with specific risks:

  • The Clock is Ticking: They must finish a merger by February 9, 2028. If they fail, the company shuts down, and your $200 million is returned to shareholders at roughly $10.00 per share, plus interest.
  • Target Quality: There is no guarantee they will find a healthy company. If they buy a business with poor finances, your investment could drop below the $10.00 price.
  • Conflicts of Interest: Leaders might feel pressured to close a deal to avoid shutting down. Because their "Founder Shares" were purchased for only $25,000, they stand to make a profit even if the stock price drops below $10.00, creating a gap between their interests and yours.

5. Future outlook

The team is currently hunting for a partner in the tech and healthcare sectors, targeting companies worth $500 million to $1 billion. They are competing with roughly 200 other SPACs for similar opportunities.

6. Market trends

SPACs are sensitive to the broader economy. High interest rates can make it more attractive for private companies to pursue a traditional IPO rather than merging with a SPAC. Furthermore, current government regulations have added complexity to the deal-making process, which may influence the timeline for a potential merger.


Investor Takeaway: Cambridge Acquisition Corp. is essentially a holding tank for cash. Your investment is a bet on the management team’s ability to find a high-quality private company to take public before their 2028 deadline. If you are considering this, keep a close eye on their merger announcements and remember that the primary safety net is the return of your capital if no deal is reached.

Risk Factors

  • The company must complete a merger by February 9, 2028, or face liquidation.
  • Potential conflicts of interest between management and public shareholders regarding deal quality.
  • Market volatility and high interest rates may hinder the ability to secure a favorable merger.

Why This Matters

Stockadora surfaced this report because Cambridge Acquisition Corp represents a classic 'blank check' play at a time when the SPAC market is cooling. With a clear 2028 deadline and a specific focus on tech and healthcare, it serves as a litmus test for investor appetite in the current high-interest-rate environment.

This filing is particularly notable for the transparency regarding management's conflicts of interest and the $7 million in deferred banking fees, which highlight the high stakes involved in the race to secure a merger before the clock runs out.

Financial Metrics

Capital Raised $200 million
2025 Net Loss $450,000
Units Issued 20 million
Founder Shares 5 million
Deferred Banking Fees $7 million

About This Analysis

AI-powered summary derived from the original SEC filing.

Document Information

Analysis Processed

March 28, 2026 at 02:03 AM

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.